Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 223,669,740 papers from all fields of science
Search
Sign In
Create Free Account
Ro 11
Known as:
Ro-11
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Broader (3)
Chloroquine
Drug Combinations
Propylamines
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1995
1995
Bioavailability and pharmacokinetics of a new low molecular weight heparin (RO-11)--a three way cross-over study in healthy volunteers.
L. Falkon
,
D. Sáenz-Campos
,
R. Antonijoan
,
Silvia Martín
,
M. Barbanoj
,
J. Fontcuberta
Thrombosis Research
1995
Corpus ID: 20611175
1995
1995
The dithiane Ro 44-5912 enhances vinblastine sensitivity of drug resistant and parental KB lines in vivo.
J. Eliason
,
R. Sawada
,
+6 authors
H. Ramuz
European Journal of Cancer
1995
Corpus ID: 25473376
1995
1995
Kinetic Behaviour of the TFPI and Anti-FXa Effects, after the Injection of a LMWH (RO-11) in Healthy Subjects
L. Falkon
,
M. Gari
,
D. Sáenz-Campos
,
R. Antonijoan
,
M. Barbanoj
,
J. Fontcuberta
Thrombosis and Haemostasis
1995
Corpus ID: 34151982
1979
1979
Effect on paroxysmal re-entrant supraventricular tachycardia of a drug affecting calcium transport (Ro 11-1781)
R. Gmeiner
,
C. Ng
,
M. Gstöttner
European Journal of Clinical Pharmacology
1979
Corpus ID: 19498264
SummaryThe effect of Ro 11-1781, a drug that affects calcium transport, in 10 patients with paroxysmal supraventricular…
Expand
Highly Cited
1978
Highly Cited
1978
A vitamin A analogue inhibits radiation-induced oncogenic transformation
L. Harisiadis
,
Richard C. Miller
,
E. Hall
,
C. Borek
Nature
1978
Corpus ID: 4159647
The ability of vitamin A and its analogues (retinoids) to prevent chemically-induced tumours has been studied in various…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE